Back Weir, GC, Mojsov, S, Hendrick, GK, Habener, JE (March 1989) 'Glucagonlike peptide I (7-37) actions on endocrine pancreas', Diabetes , 38, 338-42
Effect of Incretin-Based Therapies on Blood Pressure: A Systematic Review and Meta-Analysis
Most patients begin to notice appetite suppression within the first few weeks of starting treatment, although individual experiences vary
Sublingual is typically appropriate for: Patients with genuine needle aversion who have avoided starting GLP-1 treatment specifically because of the injection requirement
Shorter or poorer sleep is linked with changes in metabolism, appetite, and the hormones that regulate hunger and feelings of fullness